(1)
Computer-Assisted Design of Benzoisoxazol Derivatives Inhibitors of Bromodomain-Containing Protein 4 (BRD4) With Favorable Pharmacokinetic Profile. Int. J. Pharm. Sci. Drug Res. 2023, 15 (5), 647-664. https://doi.org/10.25004/IJPSDR.2023.150514.